Investment Q&A

Q: I am looking for a good penny stock to invest in, Would this be a good stock to invest into?

Q: On May 29 U stated that Q has a $1.5m unplanned non cash items(acquistions costs).Surprise that management is unaware of this costs,which is deemed to be normal. On Jun 14,dropped 0.35(7.3%) to $4.45 on 12.7k volume which is higher than the 7k average Any news?Txs for u usual great views & services.

Q: I currently have a roughly 1/2 position (on cost) in DR and am underwater roughly 12%. I hold it for the income stream. Two questions: Do you think a full position is appropriate? Do you think the market has fully reacted to the disappointing quarter?

Thanks
Peter

Q: Last question on this company dates back to 2017. It has had a nice ride up; but is currently taking an ugly and fast ride down. Down 15% for me in about 1 week alone. My “rules” say sell! Should I? Or can hanging in anticipation of a turnaround be justified?

What does the future look like for this company based on your analysis?

Thanks.

Q: Your thoughts on today’s announcement?? Also, would you ever pick up coverage again?? Once bitten?? What would you have to see?

Q: I have a small position I'm Mgnx which is highly recommended by Hidden Gems Canada. Could I have your opinion as to the prospects of this company?

Q: While the market remains buoyant, Knight's CEO seems to be remaining patient for a major reset bringing potential buyout company prices spiralling downward. I am ok with that but he seems to have laid an egg with TherapeuticsMD by paying $20M for rights to just two of their drugs for Canada and Israel plus buying $20M of stock at $5.10 and is now down over 40% in a short time frame. What do you think of this deal and the potential of these drugs? It was, at least, good to see one company pay for rights to the rest of the world outside the US. Are they a legitimate partner?
Thanks.

Q: I don’t like to add to my losers but the price drop of SIS makes it tempting. The stock is still an expensive one but do you think the dividend will start to give it some support? I’m concidering bringing this back up to a 2.5% position as I feel there’s lots of growth potential and I have a long time horizon.

Q: Sis recently reported AGM vote results and there were significant witheld votes for the 3 Bourassa members of the board, and highest for Robert. At the same time, performance continues to be good (as you note in recent report update). However, your full report notes key person risk for the Bourassa's. What can you tell us that would explain the withheld votes? Is this a trouble signal?

Q: I do not understand what is going on at PLI.
I have many shares and want your help to sort out my options.
1. should I participate in the writes any why . Is to late ?
2. what advantage would I get if I owned the writes. Would I be able to guy shares at $ 0.0015 and how does that work.
3. Is there a chance the new management is more capable in running this company which may have solid science but has cheated it's loyal stock holder.

Q: Is Prometic Life Sciences, in your opinion, still a viable company??
I am trying to determine if the current offer of 20 shares for every share owned is worth the small investment required. The shares are currently trading at 035 cents and the offer would provide the additional shares at around a tenth of a cent (if my calculation is correct) This sounds like one of those deals that is too good to be true but I am not 100% convinced. What do you think

Thanks for your thoughts

Q: on April 12 you stated ISRG was one of your favourite growth companies what is your current opinion in light of the drop in share price from 582.85 to a current price of 467.66.? plus any reason for the huge drop in price? thanks Richard

Q: I have held MO for over 10 years. It's done very well for me - tripled in value plus dividends. But it's probably time to move on. Traditional tobacco product sales are declining rapidly (not a bad thing to be honest) and investments in JUUL and Cannibis are probably years away from potentially paying off. I'm comfortable with my portfolio make up except for healthcare, which i have no exposure to. I've been looking at ISRG, TMO, BSX and BDK. I'm leaning towards ISRG based on their balance sheet (lots of cash, very little debt),market position, and potential growth but it seems to be in the doghouse after an earnings miss last quarter and it looks expensive on a fwd P/E basis. That said I don't mind paying up for quality. Your thoughts on ISRG or maybe one of the other stocks I listed? Deduct as many credits as you see fit. Thanks in advance.

Q: Looks like interesting announcements from RHT this morning particularly the winning of new contracts and on-boarding of new patients. Your thoughts. More smoke or are these real developments.

Q: With the recent problems JNJ is facing regarding opioids, would a switch to NVS {novartis] make sense? Held in a US$ RRIF.
Thanks

Q: Good afternoon,

What is your opinion on the long term trajectory on owning JNJ should the outcome in the Oklahoma opiod prescription trial find for the state? Is this a material concern?

Thank you,

Q: Hi Folks
is it time to move on or is there still hope. Down 21% since I bought it a year ago. Can you give me a possible replacement if you think it's time to sell.
thanks

Q: Hello,

What's your take on TEVA after another big drop today?


Thank you.

Q: Please comment on earnings. Thanks

Q: As a follow up to my previous question, which one would you prefer if you had room for only one additional position at this time.